Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Administer leqemi 10 mg/kg, every two weeks.'s trials
12-Month Real-World Safety & Efficacy of Lecanemab in Early Alzheimer's Disease
Administer Leqemi 10 mg/kg, every two weeks.
Ongoing
Active not recruiting
Phase 4
Open NCT07034222 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record
NCT07034222 · Trial Tracker · ComplyRx
